These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12646928)

  • 1. The silent treatment.
    Smith C
    Nature; 2003 Mar; 422(6929):342. PubMed ID: 12646928
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug target validation: Hitting the target.
    Smith C
    Nature; 2003 Mar; 422(6929):341, 343, 345 passim. PubMed ID: 12646927
    [No Abstract]   [Full Text] [Related]  

  • 3. Unfinished business: target-based drug discovery.
    Brown D
    Drug Discov Today; 2007 Dec; 12(23-24):1007-12. PubMed ID: 18061878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic and kinetic aspects of toxicological studies. 19 May 1987, Paris, France.
    Xenobiotica; 1988 Jan; 18 Suppl 1():1-96. PubMed ID: 3344587
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of cinematography in the primary evaluation of pharmacologically-active substances].
    Sardi B; Viganò V
    Boll Chim Farm; 1980 Feb; 119(2):73-7. PubMed ID: 7459031
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies: The generation game.
    Blow N
    Nature; 2007 Jun; 447(7145):741-4. PubMed ID: 17554312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Open Field Test: reinventing the wheel.
    Stanford SC
    J Psychopharmacol; 2007 Mar; 21(2):134-5. PubMed ID: 17329288
    [No Abstract]   [Full Text] [Related]  

  • 8. Binding of drugs to hepatic microsomes: comment and assessment of current prediction methodology with recommendation for improvement.
    Hallifax D; Houston JB
    Drug Metab Dispos; 2006 Apr; 34(4):724-6; author reply 727. PubMed ID: 16552024
    [No Abstract]   [Full Text] [Related]  

  • 9. RNA interference: the silent treatment.
    Clayton J
    Nature; 2004 Sep; 431(7008):599-605. PubMed ID: 15457267
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting human pharmacokinetics from preclinical data.
    Poggesi I
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):100-11. PubMed ID: 14982153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New screening tools for lead compound identification.
    Sawyer TK
    Nat Chem Biol; 2005 Aug; 1(3):125. PubMed ID: 16408012
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
    Hengstler JG; Bolt HM
    Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA new drug approvals in 2003.
    Wynn RL
    Gen Dent; 2004; 52(4):294-8, 300. PubMed ID: 15366292
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cellular and molecular pharmacology. A new approach to the mode of action and the toxicity of medications].
    Deysson G; Migne J
    Biol Med (1971); 1974 Jun; 3(1):21-63. PubMed ID: 4470700
    [No Abstract]   [Full Text] [Related]  

  • 15. [Animal experiments in hospitals on the subject of addicting substances].
    Olivennes A; Olivennes F
    Ann Med Psychol (Paris); 1986 Feb; 144(2):184-90. PubMed ID: 3813321
    [No Abstract]   [Full Text] [Related]  

  • 16. Reference ranges for screening preclinical drug safety data.
    Amaratunga D
    J Biopharm Stat; 1997 Jul; 7(3):417-22. PubMed ID: 9252834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovering drugs through biological transformation: role of pharmacologically active metabolites in drug discovery.
    Fura A; Shu YZ; Zhu M; Hanson RL; Roongta V; Humphreys WG
    J Med Chem; 2004 Aug; 47(18):4339-51. PubMed ID: 15317447
    [No Abstract]   [Full Text] [Related]  

  • 18. Validating cancer drug targets.
    Benson JD; Chen YN; Cornell-Kennon SA; Dorsch M; Kim S; Leszczyniecka M; Sellers WR; Lengauer C
    Nature; 2006 May; 441(7092):451-6. PubMed ID: 16724057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An FDA perspective on the nonclinical use of the X-Omics technologies and the safety of new drugs.
    Jacobs A
    Toxicol Lett; 2009 Apr; 186(1):32-5. PubMed ID: 18809476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of human drug clearance using multiexponential techniques.
    Goteti K; Brassil PJ; Good SS; Garner CE
    J Clin Pharmacol; 2008 Oct; 48(10):1226-36. PubMed ID: 18559487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.